Advantage Alpha Capital Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,640	Closed	-$442K	–	159
2024 Q3	$442K	Buy	+8,640	New	+$442K	0.1%	145